Case Reports on Hematomas
Case Reports on Hematomas is a research topic within Surgery. Science Explorer counts 9.3k research works in it since 1950. 6.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management of spontaneous and iatrogenic hematomas, including retroperitoneal and rectus sheath hematomas. The papers discuss conservative management, endovascular intervention, and open surgery as treatment options, particularly in patients undergoing anticoagulant therapy. Additionally, the cluster explores complications such as femoral neuropathy and the differential diagnosis with soft tissue sarcomas.
- Hematoma
- Management
- Endovascular Intervention
- Conservative Treatment
- Rectus Sheath Hematoma
- Anticoagulant Therapy
- Femoral Neuropathy
- Embolization
- Soft Tissue Sarcoma
- Retroperitoneal Hemorrhage
- Research works
- 9.3k fractional, since 1950
- In the world top 10%
- 608 per year above
- Top-10% rate
- 6.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +17% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Case Reports on Hematomas research?
By volume, the United States and China publish the most (314 and 145 works in 2022–2025).
By volume, 2022–2025
- 1 United States 314 works
- 2 China 145 works
- 3 Japan 142 works
- 4 India 104 works
- 5 Germany 56 works
- 6 United Kingdom 52 works
- 7 Spain 44 works
- 8 Italy 39 works
- 9 South Korea 37 works
- 10 Türkiye 33 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Case Reports on Hematomas research?
By volume in 2022–2025, Icahn School of Medicine at Mount Sinai publishes the most Case Reports on Hematomas research, followed by All India Institute of Medical Sciences and Mohammed V University.
By volume, 2022–2025
- 1 Icahn School of Medicine at Mount Sinai United States 9 works
- 2 All India Institute of Medical Sciences India 6 works
- 3 Mohammed V University Morocco 6 works
- 4 Mayo Clinic in Arizona United States 5 works
- 5 Chinese Academy of Medical Sciences & Peking Union Medical College China 4 works
- 6 Sağlık Bilimleri Üniversitesi Türkiye 4 works
- 7 University of Alabama at Birmingham United States 3 works
- 8 Massachusetts General Hospital United States 3 works
- 9 Institute of Medical Sciences India 3 works
- 10 Jawaharlal Institute of Post Graduate Medical Education and Research India 3 works
Where is Case Reports on Hematomas research done?
The largest centres of Case Reports on Hematomas research in 2022–2025 are Tokyo (Japan), New York (United States), Beijing (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Tokyo and New York.
Largest cities, 2022–2025
Where it is the local speciality
- TokyoJP · 27.8 works2.5×
- New YorkUS · 21.3 works2.3×
Location quotient: how much more of its research is in Case Reports on Hematomas than the world average.
Where is the best place to study Case Reports on Hematomas?
Among universities, judged by research, Icahn School of Medicine at Mount Sinai score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Icahn School of Medicine at Mount Sinai United States | 0.0 | 0.0% | 14.3× | 9 | +135.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Case Reports on Hematomas research growing?
Output in 2018–2022 was 17% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Case Reports on Hematomas.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.